Publications

Journal Article
Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't
Ppublish 400 citations
Electronic publication date
March 6, 2010

View on Pubmed.gov 20133837 | View on doi.org 10.1073/pnas.09...

The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism.

Search for publications in this journal Proc Natl Acad Sci U S A - 107(5):1894-9

Abstract

Cancer cells preferentially metabolize glucose by aerobic glycolysis, characterized by increased lactate production. This distinctive metabolism involves expression of the embryonic M2 isozyme of pyruvate kinase, in contrast to the M1 isozyme normally expressed in differentiated cells, and it confers a proliferative advantage to tumor cells. The M1 and M2 pyruvate-kinase isozymes are expressed from a single gene through alternative splicing of a pair of mutually exclusive exons. We measured the expression of M1 and M2 mRNA and protein isoforms in mouse tissues, tumor cell lines, and during terminal differentiation of muscle cells, and show that alternative splicing regulation is sufficient to account for the levels of expressed protein isoforms. We further show that the M1-specific exon is actively repressed in cancer-cell lines--although some M1 mRNA is expressed in cell lines derived from brain tumors--and demonstrate that the related splicing repressors hnRNP A1 and A2, as well as the polypyrimidine-tract-binding protein PTB, contribute to this control. Downregulation of these splicing repressors in cancer-cell lines using shRNAs rescues M1 isoform expression and decreases the extent of lactate production. These findings extend the links between alternative splicing and cancer, and begin to define some of the factors responsible for the switch to aerobic glycolysis.

References

Methods Mol Biol. 2000;133:223-33

Nature. 2010 Jan 21;463(7279):364-8

Hum Mol Genet. 2002 Jun 15;11(13):1561-7

Cancer Res. 2002 Oct 15;62(20):5881-7

Cited by 400 citations (total)

Journal Article Research Support, Non-U.S. Gov't

Exon-centric regulation of pyruvate kinase M alternative splicing via mutually exclusive exons.

Electronic publication date August 18, 2012

Search for publications in this journal J Mol Cell Biol

Zhenxun Wang [...] Adrian R Krainer et al.

Alternative splicing of the pyruvate kinase M gene (PK-M) can generate the M2 isoform and promote aerobic glycolysis and tumor...

Journal Article

The translational landscape of the splicing factor SRSF1 and its role in mitosis.

Electronic publication date May 21, 2014

Search for publications in this journal Elife

Magdalena M Maslon [...] Javier F Cáceres et al.

The shuttling Serine/Arginine rich (SR) protein SRSF1 (previously known as SF2/ASF) is a splicing regulator that also activates translation in...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances